Glide Pharmaceutical Technologies

Activities: Drug Delivery Research & Development Pharmaceutical

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Glide Technologies collaborates with Cilian to develop flu vaccine

Will develop a solid dose formulation of CiFlu recombinant influenza vaccine
Research & Development

Glide skin delivery and human factor studies highlight ease-of-use of solid dose injection system

Company plans to evaluate octreotide product in a clinical bioequivalence study in Q4 2015
Manufacturing

AMRI to manufacture clinical trial product for Glide Technologies

Will install the clinical production line developed by Glide into its newly acquired GMP facility in Glasgow
Drug Delivery

Glide Pharma to work with Nypro Healthcare for scale-up of delivery device

Glide SDI injects drugs and vaccines in a solid dosage form without requiring a needle
Manufacturing

Glide Pharma to work with Nypro Healthcare for scale up of solid dose delivery device

The Glide SDI injects drugs and vaccines in a solid dosage form without the need for a needle
Drug Delivery

Glide Pharma raises £14m for scale up of manufacturing processes

For proprietary Glide-SDI solid dose injector system
Drug Delivery

Glide Pharma wins

Existing investors Hygea VCT and Oxford Technology VCT have made further investment in pharmaceutical firm Glide Pharma as part of a
Subscribe now